Clinical characteristics of coronavirus disease 2019 in China, The New England Journal of Medicine, 2020. ,
How to "Detronize" virus in crownquestions to current stem cell therapies, Stem Cell Reviews and Reports, 2020. ,
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 2020. ,
Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management, Clinical Gastroenterology and Hepatology, 2020. ,
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, The Journal of Pathology, vol.203, issue.2, pp.631-637, 2004. ,
, Stem Cell Rev and Rep, vol.5
Targeting ACE2/Angiotensin-(1-7)/Mas receptor axis in the vascular progenitor cells for cardiovascular diseases, Molecular Pharmacology, 2020. ,
Blood Flow Restriction Exercise Stimulates Mobilization of Hematopoietic Stem/Progenitor Cells and Increases the Circulating ACE2 Levels in Healthy adults, Journal of Applied Physiology, 1985. ,
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo, Haematologica, vol.94, issue.6, pp.857-860, 2009. ,
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement, Stem Cell Reviews and Reports, 2020. ,
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum, Nature, vol.480, issue.7378, pp.534-541, 2011. ,
Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization, Nature Medicine, vol.20, issue.7, pp.725-731, 2014. ,
A novel marker for undifferentiated human embryonic stem cells, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol.34, issue.1, pp.7-11, 2015. ,
High-throughput immunophenotypic characterization of bone marrow-and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources, Stem Cell Research & Therapy, vol.9, issue.1, p.10, 2018. ,
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 2020. ,
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, vol.395, pp.565-574, 2020. ,
Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report, Annals of Oncology, 2020. ,
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduction and Targeted Therapy, vol.5, p.33, 2020. ,
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. The Journal of Infection, 2020. ,
A possible role for B cells in COVID-19?: lesson from patients with Agammaglobulinemia, The Journal of Allergy and Clinical Immunology, 2020. ,
The interplay between CD27(dull) and CD27(bright) B cells ensures the flexibility, stability, and resilience of human B cell memory, Cell Reports, vol.30, issue.9, pp.2963-2977, 2020. ,
, Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis, vol.120, pp.538-564, 2020.
Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, Journal of Thrombosis and Haemostasis, 2020. ,
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection, Clinical Chemistry and Laboratory Medicine, 2020. ,
Coagulopathy and antiphospholipid antibodies in patients with Covid-19, The New England Journal of Medicine, vol.382, issue.17, p.38, 2020. ,
Lupus anticoagulant is frequent in patients with Covid-19, Journal of Thrombosis and Haemostasis, 2020. ,
ISTH interim guidance on recognition and management of coagulopathy in COVID-19, Journal of Thrombosis and Haemostasis, 2020. ,
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, Journal of Thrombosis and Haemostasis, 2020. ,
Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence, 2020. ,
Endothelial cell infection and endotheliitis in COVID-19, 2020. ,
Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 2020. ,
Vascular changes detected with thoracic CT in coronavirus disease (COVID-19) might be significant determinants for accurate diagnosis and optimal patient management, AJR. American Journal of Roentgenology. W1, 2020. ,
Angiogenic potential of BM MSCs derived from patients with critical leg ischemia, Bone Marrow Transplantation, vol.47, issue.7, pp.997-1000, 2012. ,
Engineering robust and functional vascular networks in vivo with human adult and cord bloodderived progenitor cells, Circulation Research, vol.103, issue.2, pp.194-202, 2008. ,
Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells, Thrombosis and Haemostasis, vol.114, issue.4, 2015. ,
Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism, Thrombosis and Haemostasis, vol.117, issue.10, pp.1908-1918, 2017. ,
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells, Blood, vol.109, issue.11, pp.4761-4768, 2007. ,
Bone marrowderived mesenchymal stem cells facilitate engineering of longlasting functional vasculature, Blood, vol.111, issue.9, pp.4551-4558, 2008. ,
Endoglin as an adhesion molecule in mature and progenitor endothelial cells: a function beyond TGF-beta, Frontiers in Medicine, vol.6, p.10, 2019. ,
Mesenchymal Stem Cells Beyond Regenerative Medicine, Frontiers in Cell and Development Biology, vol.8, p.72, 2020. ,
Mesenchymal stem cell therapy for COVID-19: present or future, Stem Cell Reviews and Reports, 2020. ,
Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia, Aging and Disease, vol.11, issue.2, pp.216-228, 2020. ,
Mesenchymal stromal cell secretome for severe COVID-19 infections: premises for the therapeutic use, Cells, issue.4, p.9, 2020. ,
Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?, Leukemia, vol.26, issue.6, pp.1166-1173, 2012. ,
Human very small embryonic-like cells support vascular maturation and therapeutic revascularization induced by endothelial progenitor cells, Stem Cell Reviews, vol.13, issue.4, pp.552-560, 2017. ,
Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential, Thrombosis and Haemostasis, vol.113, issue.5, pp.1084-1094, 2015. ,
Bone marrow very small embryonic-like stem cells: new generation of autologous cell therapy soon ready for prime time?, Stem Cell Reviews, vol.13, issue.2, pp.198-201, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01446765
Transplantation of bone marrowderived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction, Stem Cells, vol.26, issue.6, pp.1646-1655, 2008. ,
Cardiomyocyte differentiation of bone marrow-derived Oct-4 + CXCR4 + SSEA-1 + very small embryonic-like stem cells, International Journal of Oncology, vol.37, issue.2, pp.237-247, 2010. ,
Very Small Embryoniclike Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension, Stem Cell Reviews, vol.13, issue.4, pp.561-566, 2017. ,
Very small embryonic-like stem cells from the murine bone marrow differentiate into epithelial cells of the lung, Stem Cells, issue.12, pp.2759-2766, 2013. ,
Novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells, Circulation Research, vol.120, issue.1, pp.166-178, 2017. ,
, Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations